glp-1 drug market competition 2025 Receptor Agonist Valued at USD 62.86 Billion in 2025, Set to Grow at 17.5% CAGR Through 2034 GLP-1 2.0: Where the Next

The most important supplements to take while on GLP-1 medications are those that help support muscle, nutrient intake, and metabolic health

Morgan Research does not provide individually tailored investment advice

Great value for a high quality probiotic

They are intended for general informational purposes only and do not constitute a medical guarantee or promise of outcome

The clinical features of GLP-1 RA-associated BP may not always correspond to the characteristic tense blisters of classic BP, and elevated autoantibody levels can persist even as clinical symptoms improve

FDA guidance should help distinguish between noncompliant and clinically justified compounded formulations, supporting prescribers who have legitimate reasons for seeking tailored options